Boots have confirmed that 200 jobs will go at their Nottingham BCM factory over the next two years.
By modernising and improving the efficiency of our Nottingham factory, we strengthen its position for the future and make it more suited to support the increasing global footprint of our product brands. It is an important step in our continued efforts to keep contract manufacturing in the UK, despite the ongoing challenges that the industry faces.”
– Alex Gourlay, Chief Executive, Health & Beauty Division, Alliance Boots
The Nottingham based pharmaceutical, Boots, has signed a deal worth $6.7 billion with the largest drug store chain in the US.
The deal means that the US company, Walgreens, will gain a 45% stake in the British company with the option of total control by 2015.
Boots have sold the 45% stake so that they can become the first global pharmacy business with 11,000 stores in 12 countries.
The British retailer currently employs around 75,000 staff in the UK. They have also said that they are committed to keeping their current support offices across Europe as well as their operational hub in Nottingham.
The stores will continue to operate under their existing brands and the companies have said they have no plans to make any redundancies because the two businesses complement each other.